Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: Role of carcino-embryonic antigen in assessment of response

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 4973-4975

  Kern, W ^a   Beckert, B ^a   Lang, N ^a   Waggershauser, T ^a   Braess, J ^a   Schalhorn, A ^a   Hiddemann, W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Carcino embryonic antigen; Colorectal cancer; Oxaliplatin

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; AREA UNDER THE CURVE; CLINICAL ARTICLE; COLORECTAL CANCER; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG HALF LIFE; FEMALE; GASTROINTESTINAL SYMPTOM; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; MALE; MUCOSA INFLAMMATION; PAIN; PRIORITY JOURNAL; SENSORY NEUROPATHY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME;

EID: 0034451952     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. New trends in the surgical treatment of colorectal cancer liver metastases
2. Resection of colorectal liver metastases: 25-Year experience
3. Liver resection for colorectal metastases
4. Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients
5. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: A phase II trial of the Puget Sound Oncology Consortium (PSOC 1104)
6. Intra-arterial infusion: Overview and novel approaches
7. Therapy for advanced colorectal cancer
8. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver
9. Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases
10. The value of postoperative hepatic arterial infusion following curative liver resection
11. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin
12. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
13. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
14. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver
15. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
16. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer
17. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis
18. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma
19. Role of carcinoembryonic antigen in the management of advanced colorectal cancer
20. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer
21. Oxaliplatin pharmacokinetics during a four-hour infusion
22. Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models
23. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer
24. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer